Nutrigenetic Effect on Intestinal Absorption
41
Christen, W. G. (1999). Antioxidant vitamins and age-related eye disease. Proc. Assoc. Am. Phys., 111, 16–21. During, A., Dawson, H. D., & Harrison, E. H. (2005). Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe. J. Nutr., 135, 2305–2312. Fairfield, K. M., & Fletcher, R. H. (2002). Vitamins for chronic disease prevention in adults: scientific review. JAMA, 287, 3116–3126. Gale, C. R., Hall, N. F., Phillips, D. I., & Martyn, C. N. (2003). Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 44, 2461–2465. Holick, M. F. (2005). Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South. Med. J., 98, 1024–1027. Hollander, D. (1981). Intestinal absorption of vitamin A, E, D, and K. J. Lab. Clin. Med., 97, 449–462. Jime´nez-Jime´nez, F. J., Molina, J. A., Fernandezcalle, P., et al. (1993). Serum levels of beta-carotene and other carotenoids in Parkinson’s disease. Neurosci. Lett., 157, 103–106. Kawaguchi, R., Yu, J., Honda, J., et al. (2007). A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science, 315, 820–825. Knekt, P., Ritz, J., Pereira, M. A., et al. (2004). Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am. J. Clin. Nutr., 80, 1508–1520. Mares-Perlman, J. A., Millen, A. E., Ficek, T. L., & Hankinson, S. E. (2002). The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. J. Nutr., 132, 518S–524S. Moussa, M., Landrier, J. F., Reboul, E., et al. (2008). Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not niemann pick C1-like. J. Nutr., 138, 1–5. Nicoletti, G., Crescibene, L., Scornaienchi, M., et al. (2001). Plasma levels of vitamin E in Parkinson’s disease. Arch. Gerontol. Geriatr., 33, 7–12. Omenn, G. S., Goodman, G., Thornquist, M. R., et al. (1994). The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations, smokers and asbestos-exposed workers. Cancer Res., 54, S2038–S2043. Osganian, S. K., Stampfer, M. J., Rimm, E., Spiegelman, D., Manson, J. E., & Willett, W. C. (2003). Dietary carotenoids and risk of coronary artery disease in women. Am. J. Clin. Nutr., 77, 1390–1399. Quilez, J., Garcia-Lorda, P., & Salas-Salvado, J. (2003). Potential uses and benefits of phytosterols in diet: present situation and future directions. Clin. Nutr., 22, 343–351. Rao, A. V., & Agarwal, S. (1999). Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: A review. Nutr. Res., 19, 305–323. Rautalahti, M., Albanes, D., Virtamo, J., Taylor, P. R., Huttunen, J. K., & Heinonen, O. P. (1997). Beta-carotene did not work: Aftermath of the ATBC study. Cancer Lett., 114, 235–236. Reboul, E., Abou, L., Mikail, C., et al. (2003). Lutein is apparently absorbed by a carrier-mediated transport process in Caco-2 cells. Clin. Nutr., 22, S103. Reboul, E., Abou, L., Mikail, C., et al. (2005). Lutein transport by Caco-2 TC-7 cells occurs partly by a facilitated process involving the scavenger receptor class B type I (SR-BI). Biochem. J., 387, 455–461. Reboul, E., Klein, A., Bietrix, F., et al. (2006). Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J. Biol. Chem., 281, 4739–4745. Reboul, E., et al. (2009). ATP-binding cassette transporter A1 is significantly involved in the intestinal absorption of alpha- and gamma-tocopherol but not in that of retinyl palmitate in mice. Am. J. Clin. Nutr., 89, 177–184. Sesso, H. D., Liu, S., Gaziano, J. M., & Buring, J. E. (2003). Dietary lycopene, tomatobased food products and cardiovascular disease in women. J. Nutr., 133, 2336–2341.